Strategy – HKAPI

23 Oct 26

CEO Meeting – Enlistment of Innovative Medicine in Hong Kong

HKAPI held its CEO Meeting on 23 October 2026 to brought together member company leaders, Board members, Task Force representatives, and external experts to discuss how Hong Kong can build a more transparent, structured, and value-based pathway for enlisting innovative medicines.

25 Jun 26

Innovation for a Sustainable Healthcare System: HKAPI Celebrates Its 58th Anniversary Dinner

On 25 June 2026, the Hong Kong Association of Pharmaceutical Industry (HKAPI) joyfully celebrated its 58th Anniversary Dinner — a milestone evening that united approximately 300 distinguished guests in a shared vision for the future of healthcare in Hong Kong.

29 Jan 26

2026 GBA Real-world Research and Application Forum

Co‑organized with GBAICTI and its key facility RWSAC, the 2026 GBA Real-world Research and Application Forum brought together representatives from government, regulatory authorities, academia, and industry across overseas, the Chinese Mainland and GBA, including Hong Kong.

29 Sep 25

Policy Address 2025: Government Policy Briefing for HKAPI Members

HKAPI hosted an exclusive policy briefing for its members with presentations from officials of the Health Bureau, Department of Health, Hospital Authority, and GBAICTI. The briefing highlighted key initiatives from the recent Policy Address impacting the pharmaceutical industry

15 Aug 25

CEO Meeting: Understanding the IMACE & Policy Address

On 15 August 2025, the HKAPI hosted its 4th CEO Meeting of the 2024–2026 term, bringing together General Managers, CEOs, and Directors from 15 member companies.

02 Apr 25

Update on Drug Enlistment & Reimbursement

The HKAPI Drug Enlistment & Reimbursement Project Team recently hosted an online sharing session on April 2 to update members on communications with the Hospital Authority regarding the new drug enlistment mechanism.

26 Mar 25

HKAPI 57th Annual General Meeting

The HKAPI is pleased to announce that the 57th Annual General Meeting (AGM) was held successfully on 26 March 2025, with over 50 General Managers and Senior Management in attendance.

27 Jan 25

Welcome Bloomberg as HKAPI’s Catalyst Member

We are delighted to welcome Bloomberg as a Catalyst Member of the Hong Kong Association of the Pharmaceutical Industry (HKAPI).

29 Aug 24

Seminar: Developing Hong Kong as a Medical Innovation Hub

"Developing Hong Kong as a Medical Innovation Hub," was held in collaboration with OASES. This event gathered prominent experts from Hong Kong's dynamic life and health technology sectors to showcase the city’s potential as a leading center for medical innovation.

13 Aug 24

Welcome Edelman as HKAPI’s First Catalyst Member

We are delighted to welcome Edelman as the first Catalyst Member of the Hong Kong Association of the Pharmaceutical Industry (HKAPI) since the recent membership restructure.